liquiritigenin has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, B; Cai, T; Qin, K; Shi, C; Wu, H; Wu, L; Xu, K | 1 |
1 other study(ies) available for liquiritigenin and Cardiotoxicity
| Article | Year |
|---|---|
Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biological Availability; Cardiotonic Agents; Cardiotoxicity; Doxorubicin; Emulsions; Female; Flavanones; Heart; Male; Mice, Inbred C57BL; Mice, Nude; Myocardium; NF-kappa B; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species | 2020 |